ACTO Introduces Role-Based AI SuperAgents for Life Sciences Teams
TECHNOLOGY
The emergence of agentic AI is redefining customer-facing operations, enabling scalable intelligence that is empathetic, connected, and compliant.
ACTO has launched SuperAgents, an AI innovation designed to transform how Life Sciences customer-facing professionals work. Unlike traditional AI tools that focus on isolated tasks and workflows, ACTO SuperAgents are built around the workforce itself, empowering individuals in their roles with intelligent, contextual, and compliant support.
The Toronto and New York-based company, which specializes in uniting human intelligence with empathetic AI in Life Sciences, positions the technology as setting a new standard for how AI can serve the industry. Rather than offering a fragmented collection of tools, SuperAgents function as a cohesive, human-centered force multiplier.
Addressing Industry Challenges
Life Sciences organizations face mounting pressure to do more with less. Many have turned to AI only to encounter siloed, role-blind solutions that create more complexity than value. ACTO's SuperAgents address this challenge by delivering a fundamentally new approach: role-based AI agents that work alongside individuals instead of within systems.
"We're at a pivotal moment in technological innovation," said Parth Khanna, CEO of ACTO. "AI is already transforming drug discovery, cutting years from development timelines and accelerating the delivery of new therapies to market. Our goal is to bring that same velocity to the post-approval phase, equipping customer-facing teams with role-based SuperAgents that automate workflows and free up more time to engage with healthcare professionals, ultimately helping get therapies to the patients waiting in need."
Empathetic AI Technology
ACTO SuperAgents are uniquely designed with empathetic AI, enabling them to understand not just a user's role, but the individual themselves, how they work, what they need, and how to best support them in real time. This awareness enables SuperAgents to deliver accurate, relevant, and immediate actions through four foundational pillars.
Context provides rich awareness of the user's role, responsibilities, and personal working patterns to deliver tailored insights. Connection ensures seamless integration with enterprise systems and other agents to orchestrate work critical to the role. Control establishes robust governance and compliance frameworks, including audit trails and human-in-the-loop oversight. Change management ensures the technology augments humans rather than replacing them, making value clear and incentivizing continuous use.
Role-Specific Capabilities
ACTO SuperAgents are preconfigured with role-specific skills to support a wide range of Life Sciences functions, including Sales, Medical, Marketing, Learning and Development, Patient Services, and Market Access. Each SuperAgent is designed using the blueprint organizations already have, the job description, to simplify work, eliminate friction, and enable professionals to operate at their highest level.
Early adopters are already seeing transformative results. Currax Pharmaceuticals is leveraging ACTO SuperAgents to empower its commercial field organization, including sales representatives and first-line managers.
"With ACTO SuperAgents, our field sales teams get instant access to critical information, from disease state science to compliance policies, without searching across systems," said Lisa Dreher, Director of National Sales Training at Currax Pharmaceuticals. "What once took hours now takes seconds, keeping reps focused in the field. We've accelerated time to field readiness, improved productivity and retention, and boosted confidence in healthcare professional interactions. The feedback from our pilot was immediate, teams called it a game-changer before full rollout."
About ACTO
ACTO is trusted by 14 of the top 50 pharmaceutical companies, high-growth biotechs, and leading medtech organizations. The company redefines how therapies reach patients after regulatory approval by uniting human intelligence with empathetic AI through its AI-powered Field Excellence Platform and AI SuperAgents.
The technology accelerates product launches, strengthens field execution, and deepens customer engagement. By elevating training and coaching while automating up to 30 percent of the work embedded in customer-facing roles, ACTO frees teams to focus on human connection, judgment, and strategic execution.
Built to meet the industry's highest regulatory standards, ACTO is FDA 21 CFR Part 11 validated and SOC 2 Type II certified. For more information or to request a demo, visit www.acto.com/SuperAgents.